Search Results - Jane Meisel

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Overwhelming Watery Diarrhea Associated with a Cryptosporidium in an Immunosuppressed Patient

    Overwhelming Watery Diarrhea Associated with a Cryptosporidium in an Immunosuppressed Patient by Jane Meisel, David Perera, C. Meligro, C.E. Rubin

    Published 1976
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Rectal biopsy in the diagnosis of Crohn's disease: Value of multiple biopsies and serial sectioning

    Rectal biopsy in the diagnosis of Crohn's disease: Value of multiple biopsies and serial sectioning by Christina M. Surawicz, Jane Meisel, Thomas J. Ylvisaker, David Saunders, C.E. Rubin

    Published 1981
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    The role of systemic chemotherapy in the management of granulosa cell tumors

    The role of systemic chemotherapy in the management of granulosa cell tumors by Jane Meisel, David M. Hyman, Anjali R. Jotwani, Qin Zhou, Nadeem R. Abu‐Rustum, Alexia Iasonos, Malcolm C. Pike, Carol Aghajanian

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer

    Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer by Xiaoxian Li, Ceyda Sönmez Wetherilt, Uma Krishnamurti, Jing Yang, Yamin Ma, Toncred M. Styblo, Jane Meisel, Limin Peng, Momin T. Siddiqui, Cynthia Cohen, Ritu Aneja

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Development of a risk stratification system to guide treatment for female germ cell tumors

    Development of a risk stratification system to guide treatment for female germ cell tumors by Jane Meisel, Kaitlin M. Woo, Nora Sudarsan, Jana Eng, Sujata Patil, Erin Jacobsen, Rajmohan Murali, Ginger J. Gardner, George J. Bosl, Carol Aghajanian, Darren R. Feldman

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer

    TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients... by Heather L. McArthur, Sara M. Tolaney, Rebecca Dent, Peter Schmid, Jamil Asselah, Qiang Liu, Jane Meisel, Naoki Niikura, Winnie Yeo, Gustavo Werutsky, Giampaolo Bianchini, Jay C. Andersen, Robert Kozarski, Nana Rokutanda, Barbara Pistilli, Sibylle Loibl

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    159TiP TROPION-Breast04: Phase (ph) III study of neoadjuvant (neoadj) datopotamab deruxtecan (Dato-DXd) + durvalumab (D) followed by adjuvant (adj) D vs standard of care (SoC) in treatment-naïve, triple-negative (TN) and HR-low/HER2- breast cancer (BC)

    159TiP TROPION-Breast04: Phase (ph) III study of neoadjuvant (neoadj) datopotamab deruxtecan (Dato-DXd) + durvalumab (D) followed by adjuvant (adj) D vs standard of care (SoC) in t... by Sibylle Loibl, S.M. Tolaney, P. Schmid, Barbara Pistilli, Rebecca Dent, Jamil Asselah, Q. Liu, Jane Meisel, Naoki Niikura, Y.H. Park, G. Werutsky, Giampaolo Bianchini, J.C. Andersen, R. Kozarski, N. Rokutanda, Heather L. McArthur

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)

    A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive brea... by Tejal Patel, Joe Ensor, Sarah L. Creamer, Toniva Boone, Angel Rodriguez, Poly A. Niravath, Jorge Darcourt, Jane Meisel, Xiaoxian Li, Jing Zhao, John G. Kuhn, Roberto R. Rosato, Wei Qian, Anna Belcheva, Mary R. Schwartz, Virginia Kaklamani, Jenny C. Chang

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109)

    Drug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109) by Elisa Agostinetto, Georg Pfeiler, Dominik Hlauschek, Erica L. Mayer, Matteo Lambertini, Evandro de Azambuja, M. Bellet-Ezquerra, Jane Meisel, Gábor Rubovszky, Nicholas Zdenkowski, Yelena Novik, Manuel Ruíz‐Borrego, Karen A. Gelmon, Eleftherios P. Mamounas, Hiroji Iwata, Dongrui R. Lu, Lidija Soelkner, Christian Fesl, Michael Gnant, Angela DeMichele

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer

    Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer by Veronica Jones, Hongwei Yin, Yuan Yuan, Yongzhe Wang, Sierra Min Li, Dana Aljaber, Angelica Sanchez, Christine Quinones, Daniel Schmolze, Yuan Yuan, Joanne Mortimer, Lisa D. Yee, Laura Kruper, Tijana Jovanović‐Talisman, Jerneja Tomšič, Nancy Sanchez, Tanya Chavez, Ruth O’Regan, Qamar J. Khan, Melissa B. Davis, Kevin Kalinsky, Jane Meisel, Rick A. Kittles, Lorna Rodrı́guez-Rodrı́guez, Victoria L. Seewaldt

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Diverse <i>BRCA1</i> and <i>BRCA2</i> Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

    Diverse <i>BRCA1</i> and <i>BRCA2</i> Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer by Britta Weigelt, Iñaki Comino‐Méndez, Ino de Bruijn, Lei Tian, Jane Meisel, Isaac García-Murillas, Charlotte Fribbens, Ros Cutts, Luciano G. Martelotto, Charlotte K.Y. Ng, Raymond S. Lim, Pier Selenica, Salvatore Piscuoglio, Carol Aghajanian, Larry Norton, Rajmohan Murali, David M. Hyman, Laetitia Borsu, Maria E. Arcila, Jason Konner, Jorge S. Reis‐Filho, Roger A. Greenberg, Mark E. Robson, Nicholas C. Turner

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer

    Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer by Sonali M. Smith, KERRI WACHTER, Howard A. Burris, Richard L. Schilsky, Daniel J. George, Douglas E. Peterson, Melissa L. Johnson, Merry Jennifer Markham, Kathryn F. Mileham, Muhammad Shaalan Beg, Johanna C. Bendell, Robert Dreicer, Vicki L. Keedy, Randall J. Kimple, Miriam A. Knoll, Noelle K. LoConte, Helen Mackay, Jane Meisel, Timothy J. Moynihan, Daniel A. Mulrooney, Therese M. Mulvey, Olatoyosi Odenike, Nathan A. Pennell, Katherine E. Reeder‐Hayes, Cardinale B. Smith, Ryan J. Sullivan, Robert G. Uzzo

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109)

    Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109) by Michelle J. Naughton, D M Zahrieh, Michael Gnant, Nicholas Zdenkowski, Julie Lemieux, Jun J. Mao, Vesna Bjelic‐Radisic, Eileen H. Shinn, Marija Balić, C. Thomssen, Jane Meisel, García Erika Ruiz, Sibylle Loibl, Claudine Isaacs, David Cameron, Fernando Henao, Matthew P. Goetz, C.F. Singer, Gustavo Werutsky, H.S. Rugo, Marcus Vetter, Ling‐Ming Tseng, Kathy D. Miller, Florian Fitzal, Miguel Gil‐Gil, H. Park, B. Linderholm, Emilio Bajetta, Zoneddy Dayao, Aleix Prat, Karl Ehrhardt, Otto Metzger, Amal Arahmani, Ernest H. Law, Ann H. Partridge, Lisa A. Carey, Alex Zoroufy, Amylou C. Dueck, Patrick O’Brien, Dominik Hlauschek, Angela DeMichele, Erica L. Mayer

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: